The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction

Pulmonary Pharmacology and Therapeutics

Volumn 18, Issue 1, 2005, Pages 23-31

  Deuchar, Graeme A ^a   Hicks, Martin N ^a   MacLean, Margaret R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Ketanserin; Left ventricular dysfunction; Nitric oxide; Pulmonary hypertension

Indexed keywords

KETANSERIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RABBIT;

ANIMALS; AORTA; BLOOD PRESSURE; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR; KETANSERIN; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; ORGAN SIZE; PULMONARY ARTERY; RABBITS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN ANTAGONISTS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 10644271844     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.07.006     Document Type: Article

References (32)

1. M. Enriquez Sarano, A. Rossi, J.B. Seward, K.R. Bailey, and A.J. Tajik Determinants of pulmonary hypertension in left ventricular dysfunction JACC 29 1997 153 159
2. M.R. MacLean, P. Herve, S. Eddahibi, and S. Adnot 5-Hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension Br J Pharmacol 131 2000 161 168
3. I. Morecroft, and M.R. MacLean 5-Hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries Br J Pharmacol 125 1998 69 78
4. 1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone Pulm Pharm 7 1994 65 72
5. 1-like receptor mediated vasoconstriction in human pulmonary artery Br J Pharmacol 119 1996 277 282
6. B.L. Fanburg, and S.L. Lee A new role for an old molecule: 5-HT as a mitogen Am J Physiol 16 1997 L795 L806
7. P. Herve, J.M. Launay, M.L. Scrobohaci, F. Brenot, G. Simonneau, and P. Petitpretz Increased plasma serotonin in primary pulmonary hypertension Am J Med 99 1995 249 254
8. Y. Kanai, S. Hori, T. Tanaka, M. Yasuoka, K. Watanabe, and N. Aikawa Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats Cardiovasc Res 27 1993 1619 1623
9. S. Eddahibi, B. Raffestin, I. Pham, J-M. Launay, P. Aegerter, and M. Sitbon Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats Am J Physiol 272 1997 H1173 H1181
10. L. Abenhaim, Y. Moride, F. Brenot, S. Rich, J. Benichou, and X. Kurz Appetite-suppresant drugs and the risk of primary pulmonary hypertension New Engl J Med 335 1996 609 616
11. G. Simonneau, M. Fartoukh, O. Sitbon, M. Humbert, J.-L. Jagot, and P. Herve Primary pulmonary hypertension with the use of fenfluramine derivatives 114 1998 195s 199s
12. C. Brink, C. Cerrina, C. Labat, J. Verley, and J. Benveniste The effect of contractile agonists on isolated pulmonary arterial and venous muscle preparations derived from patients with primary pulmonary hypertension Am Rev Resp Dis 137 1988 A106
13. M.R. MacLean, G. Sweeney, M. Baird, K.M. McCulloch, M. Houslay, and I. Morecroft 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats Br J Pharmacol 119 1996 917 930
14. G.A. Deuchar, M.N. Hicks, S.M. Cobbe, C.C. Docherty, and M.R. MacLean Pulmonary responses to 5-hydroxytrytamine and endothelin-1 in a rabbit model of left ventricular dysfunction Cardiovasc Res 38 1998 500 507
15. 1B receptor Br J Pharmacol 128 1999 730 734
16. M.D. McGoon, and R.E. Vliestra Acute haemodynamic response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary hypertension Int J Cardiol 14 1987 303 309
17. P.J. Van Der Starre, R.J. Field, and R.S. Reneman Ketanserin in the treatment of pulmonary hypertension after valvular surgery: a comparison with nitroprusside Crit Care Med 17 1989 613 618
18. E. Glusa, and A. Roos Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine Br J Pharmacol 119 1996 330 334
19. 2B receptors Br J Pharmacol 130 2000 692 698
20. M.P. Pye, M. Black, and S.M. Cobbe Comparison of in vivo and in vitro haemodynamic function in experimental heart failure: use of echocardiography Cardiovasc Res 31 1996 873 881
21. C. Hunter, G.R. Barer, J.W. Shaw, and E.J. Clegg Growth of the heart and lungs in hypoxic rodents: a model of human hypoxic disease Clin Sci Mol Med 46 1974 375 391
22. J.C. Wanstall, and S.R. O'Donnell Endothelin and 5-hydroxytryptamine on the rat pulmonary artery in pulmonary hypertension Eur J Pharmacol 176 1990 159 168
23. P.M. Vanhoutte, and T.F. Luscher Serotonin and the blood vessel wall J Hypertens 4 1986 S29 S35
24. P.M. Vanhoutte, S.G. Ball, A. Berdeaux, M.L. Cohen, T. Hedner, and R. McCall Mechanism of action of ketanserin in hypertension TIPS 7 1986 58 59
25. B receptors in rabbit pulmonary resistance arteries: effect of left ventricular dysfunction J Pharm Exp Ther 284 1998 895 903
26. G.A. Deuchar, A. Docherty, M.R. MacLean, and M.N. Hicks Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone Br J Pharmacol 135 2002 1060 1068
27. J. Loscalzo Editorial. Endothelial dysfunction in pulmonary hypertension N Engl J Med 327 1992 117 119
28. C. Block, and A. Stalcup Metabolic functions of the lung. Of what clinical relevance? Chest 81 1982 215 223
29. Z. Yang, V. Richard, L. Von segesser, E. Bauer, P. Stulz, and M. Turina Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 82 1990 188 195
30. 1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy Br J Pharmacol 134 2001 614 620
31. 1B/1D-receptor antagonist GR127935 Circ Res 89 2001 1231 1239
32. MacLean MR. Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension? J Lab Clin Med 1999;134:105-14.